Daniel Engels

15PUBLICATIONS
75CO-AUTHORS
Optical technologyMedical infection agents (incl. prions)Immunogenetics (incl. genetic immunology)Pacific Peoples and disabilityNeurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jul 02, 2026
Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD: A Multicenter Cohort Study.

|Apr 08, 2026
Hyperreflective Foci in the Inner Nuclear Layer: Proof-of-Concept for an Optical Coherence Tomography Derived Microglia-Related Marker in Multiple Sclerosis.

Jonathan A Gernert, Laura M Bartos, Tara Christmann

|Feb 04, 2026
Age, Low Immunoglobulin G, and M Serum Levels Predict Infections in People With AQP4-IgG+ NMOSD Treated With Rituximab-A Multicenter Cohort Study From the German Neuromyelitis Optica Study Group (NEMOS).

Daniel Engels, Mariella Herfurth, Joachim Havla

|Oct 24, 2025
Dyadic Coping of NMOSD and MOGAD patients and their partners: a sociological and psychological examination of strategies (CoMMOnsense-Study).

Anna Walz, Daria Tkachenko, Martin W Hümmert

|Jun 10, 2025
Rituximab as First-Line Compared to Escalation Immunotherapy Is Associated With Lower Disability Accumulation in Aquaporin-4-IgG-Positive Neuromyelitis Optica Spectrum Disorder: A Multicenter Cohort Study From Germany and the United Kingdom.

Daniel Engels, Chiara Rocchi, Mirasol Forcadela

|Dec 27, 2024
Real-world multicentre cohort study on choices and effectiveness of immunotherapies in NMOSD and MOGAD.

Vivien Häußler, Corinna Trebst, Daniel Engels

Pageof 3

Frequent Collaborators

11 joint publications

Tania Kümpfel

7 joint publications

Joachim Havla

6 joint publications

Marius Ringelstein

6 joint publications

Vivien Häußler